Changes in medical oncology admissions for the management of breast cancer complications: An Australian institution's experience
被引:4
作者:
Day, Fiona L.
论文数: 0引用数: 0
h-index: 0
机构:
Calvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, AustraliaCalvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, Australia
Day, Fiona L.
[1
]
Bull, James M.
论文数: 0引用数: 0
h-index: 0
机构:
Calvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, AustraliaCalvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, Australia
Bull, James M.
[1
]
Lombard, Janine M.
论文数: 0引用数: 0
h-index: 0
机构:
Calvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, AustraliaCalvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, Australia
Lombard, Janine M.
[1
]
Stewart, John F.
论文数: 0引用数: 0
h-index: 0
机构:
Calvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, AustraliaCalvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, Australia
Stewart, John F.
[1
]
机构:
[1] Calvary Mater Newcastle Hosp, Dept Med Oncol, Reg Mail Ctr, Sydney, NSW, Australia
Aims: There is a scarcity of data regarding medical hospitalizations for breast cancer. The aim was to determine whether the burden of inpatient care for breast cancer was declining. Methods: A retrospective study was conducted of all admissions to a single medical oncology inpatient unit in 1996 and 2006 related to the treatment of breast cancer. The total number of hospitalizations, patients' length of stay in hospital, clinical indications for hospitalization and utilization of inpatient services were determined. Data analysis involved pairwise comparisons between the cohorts. Results: The total number of breast cancer hospitalizations was similar in 1996 and 2006. However, the number of hospitalizations for adjuvant treatment complications was 50% lower in 2006, attributable to a lower rate of chemotherapy-associated febrile neutropenia. Acute clinical problems necessitating inpatient care differed between 1996 and 2006. Fewer hospitalizations for symptomatic hypercalcemia, uncontrolled pain and chemotherapy toxicity were required in 2006 but a significant increase was seen in central nervous system complications. Recent practice involved greater inpatient consultation of other medical and surgical teams. There was a trend towards a shorter duration of admissions in 2006 in both adjuvant and metastatic patients. Conclusion: Although total annual breast cancer admission numbers and length of stay did not change significantly, hospitalization for treatment-related complications was less frequent in 2006. The clinical manifestations of metastatic breast cancer appear to be changing, and in our institution are being managed with broader multidisciplinary care.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 32 条
[1]
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Fong, Peter C.
Boss, David S.
论文数: 0引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, NetherlandsRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Boss, David S.
Yap, Timothy A.
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Yap, Timothy A.
Tutt, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England
Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Tutt, Andrew
Wu, Peijun
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England
Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Wu, Peijun
Mergui-Roelvink, Marja
论文数: 0引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, NetherlandsRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Mergui-Roelvink, Marja
Mortimer, Peter
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Mortimer, Peter
Swaisland, Helen
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Macclesfield, Cheshire, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Swaisland, Helen
Lau, Alan
论文数: 0引用数: 0
h-index: 0
机构:
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Lau, Alan
O'Connor, Mark J.
论文数: 0引用数: 0
h-index: 0
机构:
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
O'Connor, Mark J.
Ashworth, Alan
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Ashworth, Alan
Carmichael, James
论文数: 0引用数: 0
h-index: 0
机构:
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Carmichael, James
Kaye, Stan B.
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Kaye, Stan B.
Schellens, Jan H. M.
论文数: 0引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, Netherlands
Univ Utrecht, Dept Pharmaceut Sci, Utrecht, NetherlandsRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Schellens, Jan H. M.
de Bono, Johann S.
论文数: 0引用数: 0
h-index: 0
机构:
Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Fong, Peter C.
Boss, David S.
论文数: 0引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, NetherlandsRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Boss, David S.
Yap, Timothy A.
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Yap, Timothy A.
Tutt, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England
Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Tutt, Andrew
Wu, Peijun
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England
Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Wu, Peijun
Mergui-Roelvink, Marja
论文数: 0引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, NetherlandsRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Mergui-Roelvink, Marja
Mortimer, Peter
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Mortimer, Peter
Swaisland, Helen
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Macclesfield, Cheshire, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Swaisland, Helen
Lau, Alan
论文数: 0引用数: 0
h-index: 0
机构:
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Lau, Alan
O'Connor, Mark J.
论文数: 0引用数: 0
h-index: 0
机构:
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
O'Connor, Mark J.
Ashworth, Alan
论文数: 0引用数: 0
h-index: 0
机构:
Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Ashworth, Alan
Carmichael, James
论文数: 0引用数: 0
h-index: 0
机构:
KuDOS Pharmaceut, Cambridge, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Carmichael, James
Kaye, Stan B.
论文数: 0引用数: 0
h-index: 0
机构:Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Kaye, Stan B.
Schellens, Jan H. M.
论文数: 0引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, Netherlands
Univ Utrecht, Dept Pharmaceut Sci, Utrecht, NetherlandsRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
Schellens, Jan H. M.
de Bono, Johann S.
论文数: 0引用数: 0
h-index: 0
机构:
Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandRoyal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England